Concepedia

Amber Charlemagne

AC

Statistics

Publications

1

Citations

16

H-Index

1

Active since

2019

Affiliations

Queen Mary University of London(Current)

Amber Charlemagne is an author at Queen Mary University of London.

Publications per year

2019–2019

1

Publications

1

AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models

Stephen M. Shaw, Jenny Middleton, Kim Wigglesworth et al. · Cancer Cell International · 2019 · 16 citations · Full text

1–1 of 1